Doctor profile · Federal record
Dr. Michael Auerbach, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Baltimore, MD
- NPI 1336199942
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 48 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5233 King Ave Ste 308
Baltimore, MD 212374003
(410) 780-4050
fax (410) 780-4060 - Mailing address
-
Po Box 749495
Atlanta, GA 303749495
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- July 23, 2025
- Year of graduation
- 1978 — 48 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Maryland #D0033551
- Medicaid
- MD #404081300
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336199942. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
142,947
Distinct HCPCS
10
Medicare allowed
$1,240,809
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 78,082 | 74 | $3 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 25,900 | 175 | $21 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 21,420 | 26 | $0 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 4,910 | 11 | $27 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,834 | 24 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,582 | 544 | $8 | |
J0897 |
Injection, denosumab, 1 mg | 1,500 | 12 | $22 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,348 | 475 | $8 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 920 | 17 | $1 | |
J1750 |
Injection, iron dextran, 50 mg | 784 | 33 | $17 |
In context: peer comparison
Among 33 peers in this city , average services per provider: 1,998. This provider delivers 72× the peer median.Open Payments
Industry payments received
All-time total
$2,051
Transactions
82
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 11 | $258.72 | |
| Novartis Pharmaceuticals Corporation | 12 | $216.65 | |
| Celgene Corporation | 10 | $212.92 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $191.42 | |
| PFIZER INC. | 9 | $174.03 | |
| Genentech USA, Inc. | 5 | $121.53 | |
| Janssen Biotech, Inc. | 3 | $81.72 | |
| Astellas Pharma US Inc | 4 | $80.46 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $78.48 | |
| GlaxoSmithKline, LLC. | 5 | $75.88 | |
| Incyte Corporation | 3 | $69.73 | |
| TAIHO ONCOLOGY, INC. | 2 | $58.84 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $57.32 | |
| Mirati Therapeutics, Inc. | 2 | $53.22 | |
| Daiichi Sankyo Inc. | 3 | $47.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
226
Patients
31
Total drug cost
$1,374,392
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 63 | 19 | $2,986 |
| Acyclovir | Generic | 37 | 12 | $573 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 24 | 0 | $442,869 |
| Anastrozole | Generic | 19 | 0 | $683 |
| Imatinib Mesylate | Generic | 16 | 0 | $5,355 |
| Exemestane | Generic | 15 | 0 | $2,957 |
| Lenalidomide | Generic | 15 | 0 | $206,802 |
| Pomalyst (Pomalidomide) | Brand | 15 | 0 | $350,017 |
| Revlimid (Lenalidomide) | Brand | 11 | 0 | $196,998 |
| Venclexta (Venetoclax) | Brand | 11 | 0 | $165,151 |
Hospital affiliations
Frequently asked questions
What is Dr. Michael Auerbach's medical specialty?
Dr. Michael Auerbach practices Hematology & Oncology Physician in Baltimore, MD.
Where does Dr. Michael Auerbach practice?
Dr. Michael Auerbach practices at 5233 King Ave Ste 308, Baltimore, MD 212374003. Office phone: 4107804050.
What is Dr. Michael Auerbach's NPI?
Dr. Michael Auerbach's National Provider Identifier (NPI) is 1336199942, issued by NPPES.
Does Dr. Michael Auerbach accept Medicare assignment?
Yes. Dr. Michael Auerbach accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Auerbach commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, ferric derisomaltose, 10 mg (HCPCS J1437); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138). Source: CMS Medicare Physician & Other Practitioners file.